JPRN-UMIN000048457尚未招募未知
A multi center, phase 3 study to evaluate safety and efficacy of extensive intraoperative peritoneal lavage, that project to prevent recurrence, in the laparoscopic surgery for advanced colon cancer - SENJYO study
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group0 个研究点目标入组 2,600 人开始时间: 2022年7月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with history of surgery within 4weeks 2) Patients with multiple cancers
研究者
相似试验
进行中（未招募）
2 期
A multi center, phase 2 study to Evaluate safety and efficacy of total Neoadjuvant treatment of long courSE radiotherapy followed by cheMotherapy, capecitaBine combined with oxaliplatin (CAPOX) for Locally advanced rEctal cancer(ENSEMBLE-2)JPRN-jRCTs071210143KAGAWA Yoshinori27
进行中（未招募）
1 期
A Safety Study of Oral Edaravone in Subjects with Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-002108-41-ITMitsubishi Tanabe Development America Inc.185
进行中（未招募）
1 期
A Safety Study of Oral Edaravone in Subjects with Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-002108-41-DEMitsubishi Tanabe Pharma Development America, Inc.185
进行中（未招募）
不适用
A multicenter study of the safety and efficacy of adalimumab in subjectswith moderate to severe hidradenitis suppurativaHidradenitis SupperativaMedDRA version: 14.1Level: LLTClassification code 10020041Term: Hidradenitis suppurativaSystem Organ Class: 100000004858EUCTR2011-003406-24-DKAbbVie Deutschland GmbH & Co. KG300
进行中（未招募）
不适用
A multicenter study of the safety and efficacy of adalimumab in subjectswith moderate to severe hidradenitis suppurativaHidradenitis SupperativaMedDRA version: 14.1Level: LLTClassification code 10020041Term: Hidradenitis suppurativaSystem Organ Class: 100000004858EUCTR2011-003406-24-NLAbbVie Deutschland GmbH & Co. KG300